Search results for: 'pack screening'

The objective of this study is to assess the market potential of current testing areas pertaining to the area of genetics such as diagnostic testing/screeening, relationship testing and predictive testing. Revenue forecast has been provided for 2010-2018 for each segment within the United Kingdom, Germany, France, Italy, Spain, Scandinavia and Bene...

10 Jan 2017  |  Europe  |  Market Research

Custom Procedure Trays and Packs in Western and Eastern Europe, Forecast to 2021

With Heavy Commoditization and Low-cost Manufacturing, Product-driven Business Models are Transitioning to Service-driven Models

Infographics

×

This research service presents a detailed analysis of the European Custom Procedure Trays and Packs (CPTP) market. It provides an in-depth analysis of the market size, revenue forecast, overall as well as by surgical custom procedure trays and packs and minor procedure trays and packs and by packaging type (boxes, wraps and moulds). The surgical se...

Where there is smoke, there is fire. Businesses must recognize DDoS attacks for the data security threat that they are, instead of the simple nuisances of earlier years. In this insight, Stratecast |Frost & Sullivan details the growing threat from smoke screen DDoS attacks, and offers business leaders recommendations for properly understanding DDoS...

This report provides a strategic analysis and forecast of the HTS market. The major segments included in the scope of this report are consumables, contract screeners, and biotechnology& pharmaceuticals. Each segment covers technology, products, deals, patents, industry trends, and a revenue forecast and analysis. General market challenges, driver...

Clinical diagnostics is undergoing a radical shift, driven by omics integration for precision health, digital diagnostics services, and smart screening solutions. Digital diagnostics are streamlining data analysis and communication, and enhancing overall efficiency. Smart screening, powered by AI and machine learning, is ensuring early and accurate...

17 Jul 2017  |  North America  |  Market Research

US Oncology Diagnostics Market, Forecast to 2021

Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection

Infographics

×

Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual’s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consolida...

The International Air Transport Association (IATA) has forecast passenger traffic to nearly double from 3.8 billion in 2015 to 7.2 billion by 2030. This increase will reflect in the number of checked baggage each year with forecasts pegging the number at close to 6.5 billion bags by 2030. As airport operators revise their plans and strategies to ha...

This study explores the transformative potential of organoid technologies in advancing cancer research, precision medicine, and drug discovery. Organoids—3D cell culture systems derived from patient tumors—preserve tumor heterogeneity and provide physiologically relevant models for studying cancer biology, therapeutic response, and resistance mecha...

Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...